Base-Modified Nucleosides as Chemotherapeutic Agents: Past and Future

E-ISSN： 1873-4294|16|11|1231-1241

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.16, Iss.11, 2016-05, pp. : 1231-1241

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sugar-Modified Nucleosides in Past 10 Years, A Review

Current Medicinal Chemistry, Vol. 8, Iss. 4, 2001-03 ,pp. : 385-423

Bentham Science Publishers

Access to resources Recommend Favorite

Hybridization properties of base-modified oligonucleotides within the double and triple helix motif

By Luyten I. Herdewijn P.

European Journal of Medicinal Chemistry, Vol. 33, Iss. 7, 1998-07 ,pp. : 515-576

Elsevier

Access to resources Recommend Favorite

4’-Modified Pyrimidine Nucleosides as Potential Anti-hepatitis C Virus (HCV) Agents

Letters in Drug Design & Discovery, Vol. 11, Iss. 7, 2014-08 ,pp. : 917-921

Bentham Science Publishers

Access to resources Recommend Favorite

Acridine Derivatives as Chemotherapeutic Agents

Current Medicinal Chemistry, Vol. 9, Iss. 18, 2002-09 ,pp. : 1655-1665

Bentham Science Publishers

Access to resources Recommend Favorite

Antiangiogenesis by Chemotherapeutic Agents

Mini Reviews in Medicinal Chemistry, Vol. 5, Iss. 3, 2005-03 ,pp. : 313-317

Bentham Science Publishers

Access to resources Recommend Favorite